| Literature DB >> 35864190 |
Ricardo Moreno Traspas1,2, Tze Shin Teoh3,4, Pui-Mun Wong3, Michael Maier3, Crystal Y Chia3, Kenneth Lay3, Nur Ain Ali3, Austin Larson5, Fuad Al Mutairi6,7, Nouriya Abbas Al-Sannaa8, Eissa Ali Faqeih9, Majid Alfadhel6,10, Huma Arshad Cheema11, Juliette Dupont12, Stéphane Bézieau13, Bertrand Isidor13, Dorrain Yanwen Low14, Yulan Wang14, Grace Tan4, Poh San Lai4, Hugues Piloquet15, Madeleine Joubert16, Hulya Kayserili17, Kimberly A Kripps18, Shareef A Nahas19, Eric P Wartchow20, Mikako Warren21, Gandham SriLakshmi Bhavani22, Majed Dasouki23, Renata Sandoval24, Elisa Carvalho25, Luiza Ramos26, Gilda Porta27, Bin Wu28,29, Harsha Prasada Lashkari30,31, Badr AlSaleem32, Raeda M BaAbbad32, Anabela Natália Abreu Ferrão33, Vasiliki Karageorgou34, Natalia Ordonez-Herrera34, Suliman Khan34, Peter Bauer34, Benjamin Cogne13, Aida M Bertoli-Avella34, Marie Vincent13, Katta Mohan Girisha22, Bruno Reversade35,36,37,38,39.
Abstract
Cirrhosis is usually a late-onset and life-threatening disease characterized by fibrotic scarring and inflammation that disrupts liver architecture and function. While it is typically the result of alcoholism or hepatitis viral infection in adults, its etiology in infants is much less understood. In this study, we report 14 children from ten unrelated families presenting with a syndromic form of pediatric liver cirrhosis. By genome/exome sequencing, we found recessive variants in FOCAD segregating with the disease. Zebrafish lacking focad phenocopied the human disease, revealing a signature of altered messenger RNA (mRNA) degradation processes in the liver. Using patient's primary cells and CRISPR-Cas9-mediated inactivation in human hepatic cell lines, we found that FOCAD deficiency compromises the SKI mRNA surveillance pathway by reducing the levels of the RNA helicase SKIC2 and its cofactor SKIC3. FOCAD knockout hepatocytes exhibited lowered albumin expression and signs of persistent injury accompanied by CCL2 overproduction. Our results reveal the importance of FOCAD in maintaining liver homeostasis and disclose a possible therapeutic intervention point via inhibition of the CCL2/CCR2 signaling axis.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35864190 DOI: 10.1038/s41588-022-01120-0
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 41.307